Pil GPM-SR 1 Tablet is an oral antidiabetic medicine used for the effective management of Type 2 Diabetes Mellitus. It contains a triple combination of Glimepiride, Metformin, and Pioglitazone, which work together to control high blood sugar levels. Glimepiride increases insulin secretion from the pancreas, Metformin decreases glucose production in the liver and enhances insulin sensitivity, while Pioglitazone helps the body utilize insulin efficiently. Together, they help maintain stable blood glucose levels and lower the risk of diabetes-related complications.
Uses:
-
Management of Type 2 Diabetes Mellitus
-
Controls elevated blood glucose levels
-
Prevents diabetes-related complications such as nerve, kidney, and eye damage
-
Supports better glycemic control when combined with diet and exercise
Dosage:
The usual recommended dose is one tablet daily, or as prescribed by your doctor. The exact dose depends on your medical condition and blood sugar control. Do not skip or alter the dosage without medical advice.
How to Use:
Take Pil GPM-SR 1 Tablet with food, preferably with breakfast or your first main meal of the day, to reduce stomach upset and enhance absorption. Swallow it whole with water; do not crush or chew. Try to take it at the same time every day for consistent results.
Precautions:
-
Inform your doctor if you have liver, kidney, or heart disease.
-
Avoid alcohol, as it may increase the risk of hypoglycemia or lactic acidosis.
-
Pregnant or breastfeeding women should use this medicine only under medical supervision.
-
Regularly monitor your blood sugar levels and follow your prescribed diet and exercise plan.
Side Effects:
Common side effects may include nausea, stomach discomfort, diarrhea, headache, dizziness, or mild weight gain.
Low blood sugar (hypoglycemia) may occur if you skip meals or take it with other diabetic medications. Seek immediate medical attention if you experience sweating, shaking, rapid heartbeat, or confusion.
Pioglit 15 Tablet contains Pioglitazone (15mg), an oral antidiabetic medication used to manage type 2 diabetes mellitus. It belongs to the class of thiazolidinediones, which work by improving insulin sensitivity in the body, helping control blood sugar levels effectively.
Uses:
-
Management of type 2 diabetes mellitus
-
Improves glycemic control in combination with diet and exercise
-
Can be used alone or with other antidiabetic medications
How to Use:
Take the tablet as prescribed by your doctor, usually once daily, with or without food. Swallow whole with water.
Dosage:
Dosage is determined based on blood sugar levels, response to therapy, and other medical conditions. Do not change the dose without consulting your doctor.
Precautions:
-
Inform your doctor if you have heart, liver, or kidney problems.
-
Use cautiously in patients with a history of heart failure or fluid retention.
-
Regular monitoring of blood sugar, liver function, and weight is recommended.
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
Side Effects:
-
Weight gain, edema (fluid retention)
-
Mild hypoglycemia if combined with other antidiabetics
-
Headache, dizziness, or fatigue
-
Rare: liver enzyme elevation, heart failure, or bone fractures
Pioglit 7.5 Tablet contains Pioglitazone (7.5mg), an oral antidiabetic medication used to manage type 2 diabetes mellitus. It belongs to the class of thiazolidinediones, which improve insulin sensitivity in the body, helping control blood sugar levels effectively.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps improve glycemic control in combination with diet and exercise
-
Can be used alone or with other antidiabetic medications
How to Use:
Take the tablet as prescribed by your doctor, usually once daily, with or without food. Swallow whole with water.
Dosage:
Dosage is individualized based on blood sugar levels, treatment response, and other medical conditions. Follow your doctor’s instructions carefully.
Precautions:
-
Inform your doctor if you have heart, liver, or kidney problems.
-
Use cautiously in patients with a history of heart failure or fluid retention.
-
Regular monitoring of blood sugar, liver function, and weight is recommended.
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
Side Effects:
-
Weight gain, edema (fluid retention)
-
Mild hypoglycemia if combined with other antidiabetics
-
Headache, dizziness, or fatigue
-
Rare: liver enzyme elevation, heart failure, or bone fractures
Pioglit MF 15 Tablet ER is a combination medicine containing Pioglitazone (15mg) and Metformin (500mg) in an extended-release (ER) formulation. It is used to manage type 2 diabetes mellitus by improving insulin sensitivity and reducing glucose production in the liver.
-
Pioglitazone (15mg) improves insulin sensitivity, helping the body utilize glucose more effectively.
-
Metformin (500mg) decreases hepatic glucose production and increases peripheral glucose uptake.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps control blood sugar levels in combination with diet and exercise
-
Suitable for patients not adequately controlled on monotherapy
How to Use:
Take the tablet as prescribed by your doctor, usually once daily with food to reduce gastrointestinal side effects. Swallow whole; do not crush, chew, or split the extended-release tablet.
Dosage:
Dosage is individualized based on blood sugar levels, treatment response, and other health conditions. Follow your doctor’s instructions strictly.
Precautions:
-
Inform your doctor if you have liver, kidney, or heart problems.
-
Use cautiously in patients with a history of heart failure or fluid retention.
-
Regular monitoring of blood sugar, liver function, and kidney function is recommended.
-
Avoid alcohol while on therapy.
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
Side Effects:
-
Gastrointestinal discomfort (nausea, diarrhea)
-
Weight gain, fluid retention, or edema
-
Mild hypoglycemia if combined with other antidiabetics
-
Rare: lactic acidosis, liver enzyme elevation, or heart failure
About Pioz 15 Tablet:
Pioz 15 Tablet contains Pioglitazone, an oral hypoglycemic agent belonging to the thiazolidinedione class. It is prescribed for patients with type 2 diabetes mellitus, especially when diet, exercise, and other antidiabetic drugs are insufficient. It helps improve glycemic control and reduces insulin resistance in peripheral tissues.
How It Works:
-
Pioglitazone activates PPAR-gamma receptors in fat, muscle, and liver tissues.
-
Enhances insulin sensitivity
-
Promotes glucose uptake by muscles and reduces hepatic glucose production
-
Helps lower blood sugar levels effectively
Uses:
-
Management of type 2 diabetes mellitus
-
Improves insulin sensitivity
-
Can be used alone or in combination with other oral antidiabetics or insulin
Directions for Use:
-
Take once daily, with or without food, as prescribed by your doctor.
-
Swallow the tablet whole with water.
-
Maintain a balanced diet, exercise, and lifestyle for optimal blood sugar control.
Side Effects:
Common side effects may include:
Seek medical attention if you experience shortness of breath, swelling of legs, sudden weight gain, or signs of liver problems.
Precautions:
-
Avoid in patients with heart failure, severe liver disease, or bladder cancer history
-
Monitor blood sugar, liver function, and body weight regularly
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution in combination with insulin or other antidiabetics to prevent hypoglycemia
About Pioz 30 Tablet:
Pioz 30 Tablet contains Pioglitazone, a thiazolidinedione-class oral hypoglycemic agent. It is prescribed for patients with type 2 diabetes mellitus, especially when lifestyle modifications, diet, and other medications alone are insufficient. Pioglitazone enhances insulin sensitivity, promoting better glucose utilization and glycemic control.
How It Works:
-
Pioglitazone activates PPAR-gamma receptors in muscle, fat, and liver tissues.
-
Increases insulin sensitivity, facilitating glucose uptake by muscles.
-
Reduces hepatic glucose production, lowering overall blood sugar levels.
Uses:
-
Management of type 2 diabetes mellitus
-
Improves insulin sensitivity
-
Can be used alone or in combination with other oral antidiabetics or insulin
Directions for Use:
-
Take once daily, with or without food, as prescribed by your doctor.
-
Swallow the tablet whole with water.
-
Maintain a healthy diet, exercise, and lifestyle for optimal blood sugar control.
Side Effects:
Common side effects may include:
Seek medical attention if you experience shortness of breath, swelling, sudden weight gain, or signs of liver problems.
Precautions:
-
Avoid in patients with heart failure, severe liver disease, or a history of bladder cancer
-
Monitor blood sugar, liver function, and body weight regularly
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution when combined with insulin or other antidiabetic drugs to prevent hypoglycemia
About Pioz 7.5 Tablet:
Pioz 7.5 Tablet contains Pioglitazone, a thiazolidinedione-class oral hypoglycemic agent. It is prescribed for patients with type 2 diabetes mellitus, especially when diet, exercise, or other medications alone are insufficient. Pioglitazone works by enhancing insulin sensitivity, helping the body utilize glucose more effectively and maintain better glycemic control.
How It Works:
-
Pioglitazone activates PPAR-gamma receptors in fat, muscle, and liver tissues.
-
Improves insulin sensitivity and glucose uptake in peripheral tissues.
-
Reduces hepatic glucose production, thereby lowering blood sugar levels.
Uses:
-
Management of type 2 diabetes mellitus
-
Enhances insulin sensitivity
-
Can be used alone or in combination with other antidiabetic drugs or insulin
Directions for Use:
-
Take once daily, with or without food, as prescribed by your doctor.
-
Swallow the tablet whole with water.
-
Maintain a balanced diet, exercise routine, and healthy lifestyle to support blood sugar control.
Side Effects:
Common side effects may include:
Seek medical attention if you experience shortness of breath, swelling of legs, sudden weight gain, or signs of liver problems.
Precautions:
-
Avoid in patients with heart failure, severe liver disease, or history of bladder cancer
-
Monitor blood sugar, liver function, and weight regularly
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution when combined with insulin or other antidiabetic drugs to avoid hypoglycemia
About Pioz MF 15 Tablet SR:
Pioz MF 15 Tablet SR combines Pioglitazone, a thiazolidinedione that enhances insulin sensitivity, with Metformin, a biguanide that reduces hepatic glucose production. This combination is prescribed for patients with type 2 diabetes mellitus who require dual mechanism therapy for better glycemic control. The sustained-release (SR) formulation ensures prolonged action and convenient once-daily dosing.
How It Works:
-
Pioglitazone: Activates PPAR-gamma receptors, improving insulin sensitivity in muscle, fat, and liver tissues.
-
Metformin: Decreases hepatic glucose output and enhances peripheral glucose uptake, lowering blood sugar levels.
-
The combination provides complementary effects, addressing both insulin resistance and excess glucose production.
Uses:
-
Management of type 2 diabetes mellitus
-
Improves insulin sensitivity
-
Controls fasting and postprandial blood glucose
-
Suitable for patients requiring dual oral antidiabetic therapy
Directions for Use:
-
Take once daily, preferably with meals, as prescribed by your doctor.
-
Swallow the tablet whole, do not crush or chew.
-
Maintain a balanced diet, regular exercise, and healthy lifestyle for optimal blood sugar control.
Side Effects:
Common side effects may include:
Seek medical attention if you experience shortness of breath, swelling, sudden weight gain, or signs of liver problems.
Precautions:
-
Avoid in patients with heart failure, severe liver or kidney disease, or history of bladder cancer
-
Regular monitoring of blood sugar, kidney and liver function, and weight is recommended
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution with other antidiabetic drugs to prevent hypoglycemia
About Pioz MF G1 Tablet SR:
Pioz MF G1 Tablet SR combines Glimepiride, a sulfonylurea that promotes insulin secretion, Metformin, a biguanide that lowers hepatic glucose production, and Pioglitazone, a thiazolidinedione that enhances insulin sensitivity. This triple therapy addresses multiple mechanisms of blood sugar control in patients with type 2 diabetes mellitus who need enhanced glycemic management. The sustained-release (SR) formulation ensures convenient once-daily dosing and steady blood sugar control.
How It Works:
-
Glimepiride: Stimulates pancreatic beta cells to release insulin, lowering blood sugar.
-
Metformin: Reduces liver glucose production and increases peripheral glucose uptake.
-
Pioglitazone: Improves insulin sensitivity in muscle, fat, and liver tissues.
-
The combination provides complementary effects, controlling both fasting and postprandial blood glucose.
Uses:
-
Management of type 2 diabetes mellitus
-
Enhances insulin secretion and sensitivity
-
Controls fasting and post-meal blood sugar levels
-
Suitable for patients requiring triple oral antidiabetic therapy
Directions for Use:
-
Take once daily, preferably with meals, as prescribed by your doctor.
-
Swallow the tablet whole, do not crush or chew.
-
Maintain a balanced diet, exercise routine, and healthy lifestyle to optimize blood sugar control.
Side Effects:
Common side effects may include:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal discomfort (nausea, diarrhea)
-
Mild weight gain or edema
-
Rare: liver dysfunction or heart failure exacerbation
Seek medical attention if you experience severe dizziness, low blood sugar, swelling, or signs of liver problems.
Precautions:
-
Avoid in patients with type 1 diabetes, severe liver or kidney disease, or heart failure
-
Regular monitoring of blood sugar, liver and kidney function, and body weight is recommended
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution with other antidiabetic drugs to prevent hypoglycemia
About Pioz MF G2 Tablet SR:
Pioz MF G2 Tablet SR combines Glimepiride, a sulfonylurea that stimulates insulin secretion, Metformin, a biguanide that decreases hepatic glucose production, and Pioglitazone, a thiazolidinedione that improves insulin sensitivity. This triple therapy targets different mechanisms of blood sugar control in patients with type 2 diabetes mellitus who require enhanced glycemic management. The sustained-release (SR) formulation allows convenient once-daily dosing and steady blood sugar control.
How It Works:
-
Glimepiride: Stimulates pancreatic beta cells to release insulin, lowering blood sugar levels.
-
Metformin: Reduces glucose production in the liver and increases peripheral glucose uptake.
-
Pioglitazone: Enhances insulin sensitivity in muscle, fat, and liver tissues.
-
The combination provides complementary and effective glycemic control across fasting and postprandial periods.
Uses:
-
Management of type 2 diabetes mellitus
-
Improves insulin secretion and sensitivity
-
Controls fasting and post-meal blood sugar levels
-
Suitable for patients needing triple oral antidiabetic therapy
Directions for Use:
-
Take once daily, preferably with meals, as prescribed by your doctor.
-
Swallow the tablet whole, do not crush or chew.
-
Maintain a balanced diet, exercise routine, and healthy lifestyle for optimal glycemic control.
Side Effects:
Common side effects may include:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal discomfort (nausea, diarrhea)
-
Mild weight gain or edema
-
Rare: liver dysfunction or heart failure exacerbation
Seek medical attention if you experience severe dizziness, low blood sugar, swelling, or signs of liver problems.
Precautions:
-
Avoid in patients with type 1 diabetes, severe liver or kidney disease, or heart failure
-
Regular monitoring of blood sugar, liver and kidney function, and body weight is recommended
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Use caution with other antidiabetic drugs to prevent hypoglycemia
Remo MV 1000 Tablet is a triple-action antidiabetic medication designed for patients with type 2 diabetes mellitus requiring enhanced glycemic control. It contains:
-
Remogliflozin Etabonate 100 mg – an SGLT2 inhibitor that increases glucose excretion via urine, lowering blood sugar.
-
Vildagliptin 50 mg – a DPP-4 inhibitor that enhances insulin secretion and reduces glucagon levels, especially after meals.
-
Metformin 1000 mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity.
This combination targets multiple pathways of blood glucose regulation, providing improved glycemic control, weight management, and reduced risk of diabetes-related complications.
Uses of Remo MV 1000 Tablet
-
Management of type 2 diabetes mellitus
-
Helps lower fasting and postprandial blood sugar
-
Supports weight management in overweight diabetic patients
-
Suitable when dual therapy is insufficient
-
Reduces risk of hyperglycemia-related complications
How to Use
-
Take as prescribed by your doctor, usually once or twice daily.
-
Swallow the tablet whole with water, preferably with meals to reduce gastrointestinal discomfort.
-
Monitor blood sugar levels regularly.
-
Maintain a diabetic diet and regular exercise for optimal results.
Side Effects
Common:
-
Gastrointestinal upset (nausea, diarrhea, abdominal discomfort)
-
Increased urination or mild dehydration
-
Headache or dizziness
Less common but serious:
-
Lactic acidosis (rare, associated with Metformin)
-
Severe urinary tract infections
-
Hypoglycemia (especially if combined with other antidiabetic medications)
-
Ketoacidosis – seek immediate medical attention
Precautions & Warnings
-
Prescription Required – use only under medical supervision.
-
Inform your doctor of kidney, liver, or heart conditions before starting therapy.
-
Maintain adequate hydration to prevent dehydration.
-
Not recommended during pregnancy or breastfeeding unless prescribed.
-
Regular blood sugar and kidney function monitoring is advised.
-
Report unexplained fatigue, severe abdominal pain, or unusual muscle pain immediately.
Conclusion
Remo MV 1000 Tablet (Remogliflozin Etabonate 100 mg + Vildagliptin 50 mg + Metformin 1000 mg) is a powerful triple-action antidiabetic therapy. By targeting kidney, pancreatic, and liver pathways, it effectively lowers blood sugar, improves glycemic control, and supports weight management. When used under medical supervision along with diet and lifestyle measures, it provides comprehensive management of type 2 diabetes and helps reduce long-term complications.
Remo MV 500 Tablet is a triple-action antidiabetic medication for patients with type 2 diabetes mellitus who need better glycemic control. It contains:
-
Remogliflozin Etabonate 100 mg – an SGLT2 inhibitor that increases urinary glucose excretion, helping lower blood sugar levels.
-
Vildagliptin 50 mg – a DPP-4 inhibitor that enhances insulin secretion and reduces post-meal glucagon levels, improving postprandial glucose control.
-
Metformin 500 mg – a biguanide that reduces hepatic glucose production and improves insulin sensitivity.
By acting on multiple pathways of blood glucose regulation, this combination ensures better glycemic control, weight management, and reduced risk of diabetes-related complications.
Uses of Remo MV 500 Tablet
-
Management of type 2 diabetes mellitus
-
Helps lower fasting and postprandial blood sugar
-
Supports weight management in overweight diabetic patients
-
Suitable when dual therapy is insufficient
-
Reduces risk of hyperglycemia-related complications
How to Use
-
Take exactly as prescribed by your doctor, usually once or twice daily.
-
Swallow the tablet whole with water, preferably with meals to reduce gastrointestinal discomfort.
-
Monitor blood sugar levels regularly.
-
Maintain a diabetic diet, exercise, and lifestyle modifications for optimal results.
Side Effects
Common:
-
Gastrointestinal upset (nausea, diarrhea, abdominal discomfort)
-
Increased urination or mild dehydration
-
Headache or dizziness
Less common but serious:
-
Lactic acidosis (rare, related to Metformin)
-
Severe urinary tract infections
-
Hypoglycemia (especially if combined with other antidiabetic medications)
-
Ketoacidosis – seek immediate medical attention
Precautions & Warnings
-
Prescription Required – use only under medical supervision.
-
Inform your doctor about kidney, liver, or heart conditions before starting therapy.
-
Maintain adequate hydration to prevent dehydration.
-
Not recommended during pregnancy or breastfeeding unless prescribed.
-
Regular blood sugar and kidney function monitoring is advised.
-
Report unexplained fatigue, severe abdominal pain, or unusual muscle pain immediately.
Conclusion
Remo MV 500 Tablet (Remogliflozin Etabonate 100 mg + Vildagliptin 50 mg + Metformin 500 mg) is a triple-action antidiabetic therapy that effectively lowers blood sugar, improves glycemic control, and supports weight management. When used under medical supervision with diet and lifestyle measures, it provides comprehensive management of type 2 diabetes and helps prevent long-term complications.